Do you want to learn more about Covid-19 vaccines and the global vaccination effort? Please join The Korea Society for a conversation on COVID-19 vaccine development and distribution with Dr. Jerome Kim, Director General of International Vaccine Institute (IVI) and Tom Byrne, Korea Society President/CEO. Dr. Kim, who was named one of “The 50 Most Influential People in Vaccines” in 2014 by the vaccine industry organization Vaccine Nation, will share the importance of COVID-19 vaccines combating this prolonged pandemic. Dr. Kim will highlight the central role of IVI in accelerating safe and effective vaccines worldwide, provide the most up to date COVID-19 vaccine news, and remark on the challenges surrounding global vaccination.
COVID LESSONS FROM SOUTH KOREA:
All About COVID-19 Vaccines
with Global Vaccine Expert Dr. Jerome Kim
Premieres: Wednesday, May 19, 2021 | 7 PM (EDT)
The Korea Society
350 Madison Avenue, 24th Floor
New York, NY 10017
ABOUT THE SPEAKER
Dr. Jerome H. Kim
Director General
International Vaccine Institute
Jerome Kim, M.D., is an international expert on the evaluation and development of vaccines and is the Director General of the International Vaccine Institute (IVI), whose mission is to discover, develop and deliver safe, effective and affordable vaccines for Global Health. His depth and breadth of scientific experience span basic research through advanced clinical development. IVI’s oral cholera vaccine is used around the world to prevent this deadly diarrheal disease. IVI’s typhoid conjugate vaccine, tech-transferred to SK bioscience and PT Bio Farma, is completing Phase III testing. IVI is working on several different vaccines against COVID-19, including the clinical testing of Inovio’s DNA vaccine at Seoul National University Hospital and Genexine’s COVID-19 vaccine at Severance Hospital.
Dr. Kim was Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis ,in the U.S. Military HIV Research Program (MHRP) and also served as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity, Fort Detrick, MD. He led the Army's Phase III HIV vaccine trial (RV144) which was the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates and HIV sequence changes associated with vaccination.
